LIMAA Technologies

📍 Cologne, Germany🗓 Founded 2022👥 16 employees💰 Last funded Aug 2025
Biotechnology Research
LinkedIn
LIMAA develops a fully automated tissue preserving end-to-end histopathology platform for clinical use. This first of its kind platform allows to analyze entire tissue biospecimens in 2D and 3D without embedding or slicing while the tissue is not consumed. Preserved tissue samples are used for downstream applications leading to the unique opportunity to integrate multiplex biomarker visualization of entire tissue samples, genomics and AI guided decision making in every routine sample - no matter what sample size.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in LIMAA Technologies?
LIMAA Technologies has 1 investors on record on gritt.io, 1 mid-stage.
When did LIMAA Technologies last raise funding?
The most recent investment in LIMAA Technologies recorded on gritt.io was in August 2025.
When was LIMAA Technologies founded?
LIMAA Technologies was founded in 2022.
What industry is LIMAA Technologies in?
LIMAA Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LIMAA Technologies based?
LIMAA Technologies is headquartered in Cologne, Germany.